These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 27692463)

  • 1. Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study.
    Simon TD; Kronman MP; Whitlock KB; Gove N; Browd SR; Holubkov R; Kestle JR; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes J; Riva-Cambrin J; Rozzelle C; Shannon C; Tamber M; Wellons JC; Whitehead WE; Mayer-Hamblett N;
    J Pediatr; 2016 Dec; 179():185-191.e2. PubMed ID: 27692463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.
    Simon TD; Kronman MP; Whitlock KB; Gove NE; Mayer-Hamblett N; Browd SR; Cochrane DD; Holubkov R; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes WJ; Riva-Cambrin J; Rozzelle C; Shannon C; Tamber M; Wellons JC; Whitehead WE; Kestle JRW
    J Neurosurg Pediatr; 2018 Apr; 21(4):346-358. PubMed ID: 29393813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Treatment Characteristics by Infecting Organism in Cerebrospinal Fluid Shunt Infection.
    Simon TD; Kronman MP; Whitlock KB; Browd SR; Holubkov R; Kestle JRW; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes J; Riva-Cambrin J; Rozzelle C; Shannon CN; Tamber M; Wellons Iii JC; Whitehead WE; Mayer-Hamblett N;
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):235-243. PubMed ID: 29771360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinfection rates following adherence to Infectious Diseases Society of America guideline recommendations in first cerebrospinal fluid shunt infection treatment.
    Simon TD; Kronman MP; Whitlock KB; Browd SR; Holubkov R; Kestle JRW; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes WJ; Riva-Cambrin J; Rozzelle C; Shannon CN; Tamber M; Wellons JC; Whitehead WE; Mayer-Hamblett N
    J Neurosurg Pediatr; 2019 May; 23(5):577-585. PubMed ID: 30771757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric hydrocephalus: systematic literature review and evidence-based guidelines. Part 8: Management of cerebrospinal fluid shunt infection.
    Tamber MS; Klimo P; Mazzola CA; Flannery AM;
    J Neurosurg Pediatr; 2014 Nov; 14 Suppl 1():60-71. PubMed ID: 25988784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for first cerebrospinal fluid shunt infection: findings from a multi-center prospective cohort study.
    Simon TD; Butler J; Whitlock KB; Browd SR; Holubkov R; Kestle JR; Kulkarni AV; Langley M; Limbrick DD; Mayer-Hamblett N; Tamber M; Wellons JC; Whitehead WE; Riva-Cambrin J;
    J Pediatr; 2014 Jun; 164(6):1462-8.e2. PubMed ID: 24661340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cerebrospinal fluid parameters with treatment and complications among children with cerebrospinal fluid shunt infections: a multicenter study.
    Hawkes MT; McAlpine A; Barton M; Ranger A; Balamohan A; Davies HD; Skar G; Lefebvre MA; Almadani A; Freire D; Saux NL; Bowes J; Srigley JA; Passarelli P; Bradley J; Khan S; Purewal R; Viel-Thériault I; Robinson JL;
    J Neurosurg Pediatr; 2024 Jan; 33(1):35-43. PubMed ID: 37856380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinfection following initial cerebrospinal fluid shunt infection.
    Simon TD; Hall M; Dean JM; Kestle JR; Riva-Cambrin J
    J Neurosurg Pediatr; 2010 Sep; 6(3):277-85. PubMed ID: 20809713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of shunt infections: a multicenter pilot study.
    Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
    J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study.
    Riva-Cambrin J; Kestle JR; Holubkov R; Butler J; Kulkarni AV; Drake J; Whitehead WE; Wellons JC; Shannon CN; Tamber MS; Limbrick DD; Rozzelle C; Browd SR; Simon TD;
    J Neurosurg Pediatr; 2016 Apr; 17(4):382-90. PubMed ID: 26636251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
    Kulkarni AV; Drake JM; Lamberti-Pasculli M
    J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized study of therapy in cerebrospinal fluid shunt infection.
    James HE; Walsh JW; Wilson HD; Connor JD; Bean JR; Tibbs PA
    Neurosurgery; 1980 Nov; 7(5):459-63. PubMed ID: 7003434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery.
    Podkovik S; Zhou C; Coffin SE; Hall M; Hauptman JS; Kronman MP; Mangano FT; Pollack IF; Sedano S; Vega J; Schaffzin JK; Thorell E; Warf BC; Whitlock KB; Simon TD
    BMC Pediatr; 2024 May; 24(1):325. PubMed ID: 38734598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Arnell K; Enblad P; Wester T; Sjölin J
    J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
    James HE; Bradley JS
    Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Clinical article.
    Simon TD; Hall M; Riva-Cambrin J; Albert JE; Jeffries HE; Lafleur B; Dean JM; Kestle JR;
    J Neurosurg Pediatr; 2009 Aug; 4(2):156-65. PubMed ID: 19645551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat cerebrospinal fluid shunt infection in children.
    Kulkarni AV; Rabin D; Lamberti-Pasculli M; Drake JM
    Pediatr Neurosurg; 2001 Aug; 35(2):66-71. PubMed ID: 11549916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
    Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.